Agreement with US subsidiary of Israeli pharmaceutical giant also includes $75m provision of generic medicine doses that aid in opioid addiction and recovery
Tech Israel's Ricky Ben David talks about Teva's cannabis entry and the Facebook bill, as US correspondent Jacob Magid discusses his interviews with Nachman Shai and Merav Michaeli
Company says its generic version of Narcan is the first to arrive in markets; firm faces multiple legal challenges for allegedly stoking opioid epidemic
Pfizer, Merck, Teva, Amazon form consortium that runs AION Labs, an Israeli facility that will focus on harnessing artificial intelligence in drug development
Reuters: First-quarter profit is in line with estimates; drugmaker on track to meet 2021 targets as sales in Huntington’s treatment Austedo and migraine product Ajovy rise
Investigation looking into abuse of Israeli drugmaker's dominant market position; pharmaceutical company was sued in the US for price-fixing of same medicine
Recent comments